Study Suggests Affordable Vaccines Within Reach
Tuesday, November 3, 2009 - 08:14
in Health & Medicine
(PhysOrg.com) -- A new research paper suggests that pharmaceutical companies can afford to produce less expensive vaccines for lower-income countries because the companies can recover their research and development (R&D) costs through the sale of the vaccine to higher-priced markets. The findings are included in an article co-authored by University of Victoria health economist Rebecca Warburton being published this week in the journal Vaccine.
Read the whole article on Physorg
More from Physorg
Related
- New intranasal influenza vaccine triggers robust immunity with significantly less antigenTue, 28 Oct 2008, 14:35:32 EDT
- New test may help to ensure that dengue vaccines do no harmThu, 12 Feb 2009, 14:16:45 EST
- No scientific link between childhood vaccines and autismThu, 8 Oct 2009, 13:19:26 EDT
- Results of landmark study of HIV vaccine published in the LancetWed, 12 Nov 2008, 18:42:45 EST
- Goodbye needle, hello smoothieTue, 17 Mar 2009, 17:15:44 EDT